Mankind Pharma Limited (MANKIND) — Announcement

📢 Key Event
Mankind Pharma completes acquisition of Upakarma's remaining 10% stake

🔄 What Changed
Upakarma became a wholly owned subsidiary of Mankind Lifesciences and a step-down subsidiary of Mankind Pharma

💡 Investor Takeaway
Shareholders gain full control of Upakarma's Ayurvedic and nutraceutical business with no additional debt or dilution.

Mankind Pharma announced that its wholly owned subsidiary Mankind Lifesciences Private Limited acquired the remaining 10% stake in Upakarma Ayurveda Private Limited from Kaushcorp Media LLP via a cash share purchase agreement dated June 2, 2026, completing the acquisition and making Upakarma a wholly owned subsidiary. The transaction, valued at ₹75 Lakhs for the final stake, brings Upakarma's paid-up capital to ₹1.80 Crores and annual turnover to ₹18.02 Crores as of March 31, 2026, and falls under related party transaction regulations requiring arm's length compliance.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MANKIND ✨ Ask AI About This